Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingevity Corporation filings document formal disclosure for its specialty materials business, public-company governance, and capital structure. Form 8-K reports cover operating results, segment reporting presentation, credit agreement amendments, material agreements, and completed dispositions of North Charleston crude tall oil refinery assets and the majority of the Industrial Specialties product line.
Proxy and annual-meeting filings disclose director elections, board structure, executive compensation matters, shareholder voting results, and amendments to the company’s equity incentive plan. The filing record also includes disclosures tied to financing arrangements, continuing-operations measures, and governance matters affecting Ingevity’s common stock as a NYSE-listed issuer.
Ingevity Corp ownership filing shows 2,209,879 shares beneficially owned by Vanguard Portfolio Management, representing 6.27% of common stock. The filing reports sole voting power of 33,148 shares and sole dispositive power over 2,209,879 shares. The filing states these holdings include securities held for Vanguard funds and client accounts managed by affiliates, per SEC Release No. 34-39538.
Ingevity Corporation completed the sale of its Ozark Materials road markings business to PPG Industries in an all-cash transaction delivering approximately $65 million in proceeds to Ingevity, subject to customary adjustments.
The divestiture is limited to the Ozark Materials road markings business and does not affect Ingevity’s Pavement Technologies operations, where the company says it remains fully committed to serving paving customers. Ingevity states that the sale advances its strategy to focus on businesses aligned with its core capabilities. The company plans to update its full-year 2026 guidance for the impact of this transaction when it releases first quarter 2026 financial results, while affirming prior guidance excluding that impact.
Ingevity Corp President & CEO David H. Li reported routine tax-related share dispositions rather than open-market sales. On April 7, 2026, a total of 16,676 shares of Common Stock were withheld at $70.57 per share to cover tax obligations. After these transactions, Li directly held 140,636 shares of Ingevity common stock. A footnote notes that this total includes 422 ESPP shares purchased for the January 1 to March 31, 2026 period at 85% of the December 31, 2025 closing price.
Ingevity Corp director Francis David Segal received a grant of 329 vested deferred stock units at $72.28 per unit. These units were issued in lieu of quarterly director fees and increase his directly owned common stock-related position to 6,380 shares.
The deferred stock units will convert into an equal number of Ingevity common shares when his board service ends, under the company’s Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
Ingevity Corp director J. Kevin Willis reported an equity award of 398 shares of Common Stock on Form 4. The award reflects vested deferred stock units elected in lieu of quarterly director fees at an implied price of $72.28 per share. Following this grant, Willis directly holds 9,177 shares. These deferred stock units will convert into an equal number of Ingevity common shares when his board service ends under the company’s Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
Ingevity Corporation entered into a Second Amendment and Restatement Agreement that modifies its main credit facility. The amendment extends the maturity of the company’s revolving credit facility to a date five years after March 26, 2026 and reduces total lender commitments from $1 billion to $750 million.
Borrowings will bear interest at either a term benchmark rate, with a 0.00% floor, plus a margin of 1.00% to 1.75%, or a base rate plus a margin of 0.00% to 0.75%. On the closing date, Ingevity repaid outstanding revolving loans totaling $512.1 million.
Ingevity Corp senior executive handles RSU tax obligations through share withholding. SVP, General Counsel & Secretary Ryan C. Fisher had 308 shares of common stock withheld by the company at a price of $71.78 per share to satisfy tax liabilities from 2024 RSUs that vested. After this tax-withholding disposition, he directly holds 18,194 common shares.
The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A reporting no beneficial ownership of Ingevity Corp common stock. The filing states 0 shares and 0% ownership after an internal realignment that disaggregated certain subsidiaries' holdings in reliance on SEC Release No. 34-39538. The signature block shows Ashley Grim, Head of Global Fund Administration.
Ingevity Corporation’s 2026 proxy statement presents a transformed “New Ingevity” focused on two core specialty materials businesses: Performance Materials and Pavement Technologies. In 2025 the company completed a strategic portfolio review, agreed to sell its Industrial Specialties business and North Charleston crude tall oil refinery for $110 million and closed the divestiture on January 1, 2026.
For 2025, Ingevity reported $1.29 billion in revenue, a total adjusted EBITDA of $397.5 million and a total adjusted EBITDA margin of 30.8%, alongside a net loss of $(167.1) million. Free cash flow was $273.5 million and the net debt ratio improved to 2.6x, supported by six consecutive quarters of margin expansion.
The company returned $56 million to stockholders through share repurchases in 2025 and plans to generate approximately $1 billion in deployable cash over the next two years, including at least $300 million in additional repurchases, while funding organic growth and debt reduction. Stockholders are asked to elect nine directors, approve say‑on‑pay, ratify PwC as auditor, and increase authorized shares under the 2025 Omnibus Incentive Plan.